SGLT2 Inhibitor-induced Euglycemic Diabetic Ketoacidosis Renal Fellow Network, 08 Sep 2020 Sodium-glucose co-transporter 2 inhibitors (SGLT2is) have emerged as a breakthrough therapy for the treatment of diabetes…